Paul J. Kingma

Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

Kirsten Boonstra, Rinse K. Weersma, Karel J. van Erpecum et al. · Hepatology · 2013 · 720 citations · Full text

Medicine, Internal Medicine, Oncology +12

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial

Cyriel Y. Ponsioen, E. Joline de Groof, Emma J. Eshuis et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 356 citations

Medicine, Clinical Sciences, Surgery +12

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease

Marieke J. H. Coenen, Dirk J. de Jong, Corine J. van Marrewijk et al. · Gastroenterology · 2015 · 197 citations · Full text

Medicine, Hematology, Pharmacology +14

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial

Toer Stevens, Maria L. Haasnoot, Geert D’Haens et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 179 citations

Medicine, Surgery, Gastroenterology +10

Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in the Netherlands

E. Joline de Groof, Noortje Rossen, Bram D. van Rhijn et al. · European Journal of Gastroenterology & Hepatology · 2016 · 72 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12